These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 21105129)

  • 1. Head and neck squamous cell carcinoma: new translational therapies.
    Prince A; Aguirre-Ghizo J; Genden E; Posner M; Sikora A
    Mt Sinai J Med; 2010; 77(6):684-99. PubMed ID: 21105129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecularly targeted agents and immunotherapy for the treatment of head and neck squamous cell cancer (HNSCC).
    Azoury SC; Gilmore RC; Shukla V
    Discov Med; 2016 Jun; 21(118):507-16. PubMed ID: 27448787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunotherapy: a new alternative treatment for head and neck squamous cell carcinoma].
    Bron L; Romero P
    Bull Cancer; 2007 Sep; 94(9):793-7. PubMed ID: 17878099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy in head and neck cancer: current practice and future possibilities.
    Agada FO; Alhamarneh O; Stafford ND; Greenman J
    J Laryngol Otol; 2009 Jan; 123(1):19-28. PubMed ID: 18761763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular-targeted therapies in the treatment of squamous cell carcinomas of the head and neck.
    Le Tourneau C; Siu LL
    Curr Opin Oncol; 2008 May; 20(3):256-63. PubMed ID: 18391623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel therapeutic approaches to squamous cell carcinoma of the head and neck using biologically targeted agents.
    Harrington KJ; Kazi R; Bhide SA; Newbold K; Nutting CM
    Indian J Cancer; 2010; 47(3):248-59. PubMed ID: 20587899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment.
    Marur S; Forastiere AA
    Mayo Clin Proc; 2016 Mar; 91(3):386-96. PubMed ID: 26944243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy for Head and Neck Squamous Cell Carcinoma: A Review of Current and Emerging Therapeutic Options.
    Moskovitz JM; Moy J; Seiwert TY; Ferris RL
    Oncologist; 2017 Jun; 22(6):680-693. PubMed ID: 28507203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination antiangiogenic therapy and radiation in head and neck cancers.
    Hsu HW; Wall NR; Hsueh CT; Kim S; Ferris RL; Chen CS; Mirshahidi S
    Oral Oncol; 2014 Jan; 50(1):19-26. PubMed ID: 24269532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the Tumor Environment in Squamous Cell Carcinoma of the Head and Neck.
    Schmitz S; Machiels JP
    Curr Treat Options Oncol; 2016 Jul; 17(7):37. PubMed ID: 27262711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer.
    Linton OR; Moore MG; Brigance JS; Gordon CA; Summerlin DJ; McDonald MW
    JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1306-11. PubMed ID: 24158536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunotherapy for head and neck squamous cell carcinoma].
    Chen J; Chen M; Wu HT
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Feb; 52(2):143-147. PubMed ID: 28219181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Treatment Options in Head and Neck Cancer.
    Schuler PJ; Laban S; Doescher J; Bullinger L; Hoffmann TK
    Oncol Res Treat; 2017; 40(6):342-346. PubMed ID: 28521322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges of integrating chemotherapy and targeted therapy with radiation in locally advanced head and neck squamous cell cancer.
    Marur S; Forastiere AA
    Curr Opin Oncol; 2010 May; 22(3):206-11. PubMed ID: 20216313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological treatment options for locoregionally advanced head and neck squamous cell carcinoma.
    Schutt C; Bumm K; Mirandola L; Bernardini G; Cunha N; Tijani L; Nguyen D; Cordero J; Jenkins MR; Cobos E; Kast WM; Chiriva-Internati M
    Int Rev Immunol; 2012 Feb; 31(1):22-42. PubMed ID: 22251006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding role of the medical oncologist in the management of head and neck cancer.
    Choong N; Vokes E
    CA Cancer J Clin; 2008; 58(1):32-53. PubMed ID: 18096865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA-based immunotherapy for HPV-associated head and neck cancer.
    Aggarwal C
    Immunotherapy; 2016 Oct; 8(10):1187-92. PubMed ID: 27605067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trials, referral resource. Treatment of advanced or recurrent squamous cell carcinoma of the head and neck.
    Conley BA; Gore-Langton RE; Cheson BD
    Oncology (Williston Park); 2000 Apr; 14(4):553-4, 559, 561. PubMed ID: 10826315
    [No Abstract]   [Full Text] [Related]  

  • 19. Targeted therapy: A novel approach in head and neck cancer.
    Christy AW; Bojan A
    Indian J Dent Res; 2013; 24(2):261-6. PubMed ID: 23965459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The promise of immunotherapy in head and neck squamous cell carcinoma.
    Economopoulou P; Agelaki S; Perisanidis C; Giotakis EI; Psyrri A
    Ann Oncol; 2016 Sep; 27(9):1675-85. PubMed ID: 27380958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.